SRS Capital Advisors »

Maxcyte shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.4k 2.1k 1.58

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Maxcyte

BlackRock
Cadian Capital Management
Mirabella Financial Services
Morgan Stanley
Vanguard Group
Vitruvian Partners
Mudita Advisors
AXA Investment Managers
Geode Capital Management
State Street Corporation
Kennedy Capital Management
Dimensional Fund Advisors
Willis Investment Counsel
Citadel Advisors
Northern Trust

View all funds holding Maxcyte